HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga A Kost Selected Research

Gaucher Disease (Gaucher's Disease)

1/2018ACE phenotyping in Gaucher disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga A Kost Research Topics

Disease

3Vascular Remodeling
01/2017 - 01/2015
2Hyperemia
04/2021 - 01/2015
2Edema (Dropsy)
04/2021 - 01/2015
2Inflammation (Inflammations)
04/2021 - 01/2015
2Uveitis
04/2021 - 01/2015
1Blindness (Hysterical Blindness)
04/2021
1Eye Diseases (Eye Disease)
04/2021
1Prostatic Neoplasms (Prostate Cancer)
10/2019
1Hyperplasia
10/2019
1Gaucher Disease (Gaucher's Disease)
01/2018
1Atrial Fibrillation
01/2017
1Sarcoidosis (Schaumann Disease)
10/2016
1Cataract (Cataracts)
01/2015
1Uremia
01/2012
1Chronic Kidney Failure (Chronic Renal Failure)
01/2012
1Heart Failure
04/2007
1Hypertension (High Blood Pressure)
04/2007

Drug/Important Bio-Agent (IBA)

4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2018 - 01/2015
3Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2012
3Peptides (Polypeptides)IBA
01/2017 - 01/2015
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2016 - 04/2007
2Superoxide Dismutase-1IBA
04/2021 - 01/2015
2EnzymesIBA
04/2021 - 01/2015
2FibrinIBA
04/2021 - 01/2015
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2017 - 01/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021
1Pharmaceutical PreparationsIBA
04/2021
1AntioxidantsIBA
04/2021
1EpitopesIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
01/2017
1Muramidase (Lysozyme)IBA
10/2016
1Angiotensin IIBA
01/2012
11G12 monoclonal antibodyIBA
01/2012

Therapy/Procedure

1Therapeutics
10/2016